Senior Associate, Quality Assurance - Change Management at Eli Lilly and Company

Alzey, Rhineland-Palatinate, Germany

Eli Lilly and Company Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Healthcare, ManufacturingIndustries

Requirements

  • (No specific requirements provided in the job description.)

Responsibilities

  • Leads, mentors, and coaches operations and support personnel on the change management program
  • Facilitates the Site Change Review Board, providing board leadership to drive complete evaluation of proposed changes, including risk and impact assessment
  • Owns the site Change Management and Activity Planning programs
  • Serves as the site instructor for Change Management and Activity Planning programs, ensuring process compliance through the development of comprehensive procedures, work instructions, and personnel qualification documentation
  • Works cross-functionally with all area/function owners to manage, evaluate, implement, and document changes to ensure quality, safety, and efficacy of products
  • Monitors the change management program execution, ensuring timely approval and closure of change controls
  • Compiles, monitors, trends, and presents Change Management data
  • Maintains responsibility for a safe work environment, leading safety initiatives, and working safely; accountable for supporting all Health, Safety, and Environmental Corporate and Site Goals

Skills

Change Management
Quality Assurance
Risk Assessment
Impact Assessment
Mentoring
Cross-Functional Collaboration
Process Compliance
Data Trending
Change Control
Safety Management

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI